{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T20:17:12Z","timestamp":1789071432971,"version":"build-2803163510"},"reference-count":207,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T00:00:00Z","timestamp":1742169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T00:00:00Z","timestamp":1742169600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1007\/s12035-025-04830-8","type":"journal-article","created":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T21:53:06Z","timestamp":1742248386000},"page":"9216-9239","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Nutritional Interventions in Amyotrophic Lateral Sclerosis: From Ketogenic Diet and Neuroprotective Nutrients to the Microbiota-Gut-Brain Axis Regulation"],"prefix":"10.1007","volume":"62","author":[{"given":"Samira","family":"Nabakhteh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anahita","family":"Lotfi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arman","family":"Afsartaha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaheh Sadat","family":"Khodadadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siavash","family":"Abdolghaderi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mozhdeh","family":"Mohammadpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasaman","family":"Shokri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pouria","family":"Kiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sajad","family":"Ehtiati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4207-0114","authenticated-orcid":false,"given":"Sara","family":"Khakshournia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8579-5097","authenticated-orcid":false,"given":"Seyyed Hossein","family":"Khatami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,17]]},"reference":[{"key":"4830_CR1","doi-asserted-by":"crossref","first-page":"1064619","DOI":"10.3389\/fneur.2022.1064619","volume":"13","author":"C Falc\u00e3o de Campos","year":"2023","unstructured":"Falc\u00e3o de Campos C, Gromicho M, Uysal H, Grosskreutz J, Kuzma-Kozakiewicz M, Oliveira Santos M et al (2023) Trends in the diagnostic delay and pathway for amyotrophic lateral sclerosis patients across different countries. Front Neurol 13:1064619","journal-title":"Front Neurol"},{"issue":"9","key":"4830_CR2","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1111\/ene.15874","volume":"30","author":"KG Gwathmey","year":"2023","unstructured":"Gwathmey KG, Corcia P, McDermott CJ, Genge A, Sennf\u00e4lt S, de Carvalho M et al (2023) Diagnostic delay in amyotrophic lateral sclerosis. Eur J Neurol 30(9):2595\u20132601","journal-title":"Eur J Neurol"},{"issue":"4","key":"4830_CR3","doi-asserted-by":"crossref","first-page":"624","DOI":"10.3390\/diagnostics11040624","volume":"11","author":"R Rusina","year":"2021","unstructured":"Rusina R, Vandenberghe R, Bruffaerts R (2021) Cognitive and behavioral manifestations in ALS: beyond motor system involvement. Diagnostics 11(4):624","journal-title":"Diagnostics"},{"issue":"5","key":"4830_CR4","doi-asserted-by":"crossref","first-page":"736","DOI":"10.3390\/cells12050736","volume":"12","author":"M Vidovic","year":"2023","unstructured":"Vidovic M, M\u00fcschen LH, Brakemeier S, Machetanz G, Naumann M, Castro-Gomez S (2023) Current state and future directions in the diagnosis of amyotrophic lateral sclerosis. Cells 12(5):736","journal-title":"Cells"},{"key":"4830_CR5","doi-asserted-by":"crossref","unstructured":"Ingre C, Roos PM, Piehl F, Kamel F, Fang F (2015) Risk factors for amyotrophic lateral sclerosis.\u00a0Clin Epidemiol\u00a012:181\u201393","DOI":"10.2147\/CLEP.S37505"},{"key":"4830_CR6","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1007\/s00415-014-7445-1","volume":"261","author":"M Seelen","year":"2014","unstructured":"Seelen M, van Doormaal PT, Visser AE, Huisman MH, Roozekrans MH, de Jong SW et al (2014) Prior medical conditions and the risk of amyotrophic lateral sclerosis. J Neurol 261:1949\u20131956","journal-title":"J Neurol"},{"issue":"1","key":"4830_CR7","doi-asserted-by":"crossref","first-page":"13738","DOI":"10.1038\/s41598-022-17805-9","volume":"12","author":"C Pancotti","year":"2022","unstructured":"Pancotti C, Birolo G, Rollo C, Sanavia T, Di Camillo B, Manera U et al (2022) Deep learning methods to predict amyotrophic lateral sclerosis disease progression. Sci Rep 12(1):13738","journal-title":"Sci Rep"},{"issue":"1","key":"4830_CR8","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3390\/ph14010029","volume":"14","author":"H Cho","year":"2020","unstructured":"Cho H, Shukla S (2020) Role of edaravone as a treatment option for patients with amyotrophic lateral sclerosis. Pharmaceuticals 14(1):29","journal-title":"Pharmaceuticals"},{"issue":"2","key":"4830_CR9","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3390\/antiox11020195","volume":"11","author":"SJ Cha","year":"2022","unstructured":"Cha SJ, Kim K (2022) Effects of the edaravone, a drug approved for the treatment of amyotrophic lateral sclerosis, on mitochondrial function and neuroprotection. Antioxidants 11(2):195","journal-title":"Antioxidants"},{"issue":"5","key":"4830_CR10","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.3390\/ijms25052945","volume":"25","author":"T Yamashita","year":"2024","unstructured":"Yamashita T, Abe K (2024) Update on antioxidant therapy with Edaravone: expanding applications in neurodegenerative diseases. Int J Mol Sci 25(5):2945","journal-title":"Int J Mol Sci"},{"issue":"6","key":"4830_CR11","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.3390\/biomedicines12061294","volume":"12","author":"P Parvanovova","year":"2024","unstructured":"Parvanovova P, Evinova A, Grofik M, Hnilicova P, Tatarkova Z, Turcanova-Koprusakova M (2024) Mitochondrial dysfunction in sporadic amyotrophic lateral sclerosis patients: insights from high-resolution respirometry. Biomedicines 12(6):1294","journal-title":"Biomedicines"},{"issue":"11","key":"4830_CR12","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.3390\/genes14111981","volume":"14","author":"EC Genin","year":"2023","unstructured":"Genin EC, Abou-Ali M, Paquis-Flucklinger V (2023) Mitochondria, a key target in amyotrophic lateral sclerosis pathogenesis. Genes 14(11):1981","journal-title":"Genes"},{"key":"4830_CR13","doi-asserted-by":"crossref","first-page":"1054006","DOI":"10.3389\/fphar.2022.1054006","volume":"13","author":"J Jiang","year":"2022","unstructured":"Jiang J, Wang Y, Deng M (2022) New developments and opportunities in drugs being trialed for amyotrophic lateral sclerosis from 2020 to 2022. Front Pharmacol 13:1054006","journal-title":"Front Pharmacol"},{"issue":"3","key":"4830_CR14","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1517\/14728214.2011.604312","volume":"16","author":"AA Habib","year":"2011","unstructured":"Habib AA, Mitsumoto H (2011) Emerging drugs for amyotrophic lateral sclerosis. Expert Opin Emerg Drugs 16(3):537\u2013558","journal-title":"Expert Opin Emerg Drugs"},{"issue":"9","key":"4830_CR15","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/nrneurol.2016.111","volume":"12","author":"EV Hobson","year":"2016","unstructured":"Hobson EV, McDermott CJ (2016) Supportive and symptomatic management of amyotrophic lateral sclerosis. Nat Rev Neurol 12(9):526\u2013538","journal-title":"Nat Rev Neurol"},{"key":"4830_CR16","doi-asserted-by":"crossref","first-page":"175628561773473","DOI":"10.1177\/1756285617734734","volume":"11","author":"J Dorst","year":"2018","unstructured":"Dorst J, Ludolph AC, Huebers A (2018) Disease-modifying and symptomatic treatment of amyotrophic lateral sclerosis. Ther Adv Neurol Disord 11:1756285617734734","journal-title":"Ther Adv Neurol Disord"},{"key":"4830_CR17","doi-asserted-by":"crossref","first-page":"175628641985704","DOI":"10.1177\/1756286419857040","volume":"12","author":"J Dorst","year":"2019","unstructured":"Dorst J, Ludolph AC (2019) Non-invasive ventilation in amyotrophic lateral sclerosis. Ther Adv Neurol Disord 12:1756286419857040","journal-title":"Ther Adv Neurol Disord"},{"issue":"3","key":"4830_CR18","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1177\/0884533613476554","volume":"28","author":"DI Greenwood","year":"2013","unstructured":"Greenwood DI (2013) Nutrition management of amyotrophic lateral sclerosis. Nutr Clin Pract 28(3):392\u2013399","journal-title":"Nutr Clin Pract"},{"key":"4830_CR19","doi-asserted-by":"crossref","first-page":"68","DOI":"10.3389\/fneur.2019.00068","volume":"10","author":"M-L Campanari","year":"2019","unstructured":"Campanari M-L, Bourefis A-R, Kabashi E (2019) Diagnostic challenge and neuromuscular junction contribution to ALS pathogenesis. Front Neurol 10:68","journal-title":"Front Neurol"},{"key":"4830_CR20","doi-asserted-by":"crossref","first-page":"252","DOI":"10.3389\/fnins.2014.00252","volume":"8","author":"EB Moloney","year":"2014","unstructured":"Moloney EB, de Winter F, Verhaagen J (2014) ALS as a distal axonopathy: molecular mechanisms affecting neuromuscular junction stability in the presymptomatic stages of the disease. Front Neurosci 8:252","journal-title":"Front Neurosci"},{"issue":"11","key":"4830_CR21","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1002\/acn3.51895","volume":"10","author":"J Roggenbuck","year":"2023","unstructured":"Roggenbuck J, Eubank BH, Wright J, Harms MB, Kolb SJ, Testing AG et al (2023) Evidence-based consensus guidelines for ALS genetic testing and counseling. Ann Clin Transl Neurol 10(11):2074\u20132091","journal-title":"Ann Clin Transl Neurol"},{"issue":"5\u20136","key":"4830_CR22","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1080\/21678421.2023.2173015","volume":"24","author":"AA Dilliott","year":"2023","unstructured":"Dilliott AA, Al Nasser A, Elnagheeb M, Fifita J, Henden L, Keseler IM et al (2023) Clinical testing panels for ALS: global distribution, consistency, and challenges. Amyotroph Lateral Scler Frontotemporal Degener 24(5\u20136):420\u2013435","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"issue":"3","key":"4830_CR23","doi-asserted-by":"crossref","first-page":"525","DOI":"10.3390\/cells10030525","volume":"10","author":"S Scaricamazza","year":"2021","unstructured":"Scaricamazza S, Salvatori I, Ferri A, Valle C (2021) Skeletal muscle in ALS: an unappreciated therapeutic opportunity? Cells 10(3):525","journal-title":"Cells"},{"issue":"11","key":"4830_CR24","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.3390\/biom13111582","volume":"13","author":"E Duranti","year":"2023","unstructured":"Duranti E, Villa C (2023) Muscle involvement in amyotrophic lateral sclerosis: understanding the pathogenesis and advancing therapeutics. Biomolecules 13(11):1582","journal-title":"Biomolecules"},{"key":"4830_CR25","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s00401-017-1708-8","volume":"133","author":"J Nijssen","year":"2017","unstructured":"Nijssen J, Comley LH, Hedlund E (2017) Motor neuron vulnerability and resistance in amyotrophic lateral sclerosis. Acta Neuropathol 133:863\u2013885","journal-title":"Acta Neuropathol"},{"key":"4830_CR26","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.brainresbull.2018.05.023","volume":"140","author":"MJ Fogarty","year":"2018","unstructured":"Fogarty MJ (2018) Driven to decay: excitability and synaptic abnormalities in amyotrophic lateral sclerosis. Brain Res Bull 140:318\u2013333","journal-title":"Brain Res Bull"},{"issue":"1","key":"4830_CR27","volume":"12","author":"AG Temp","year":"2022","unstructured":"Temp AG, Kasper E, Vielhaber S, Machts J, Hermann A, Teipel S et al (2022) Loss of \u201cinsight\u201d into behavioral changes in ALS: differences across cognitive profiles. Brain and behavior 12(1):e2439","journal-title":"Brain and behavior"},{"issue":"1\u20132","key":"4830_CR28","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3109\/17482960903171110","volume":"11","author":"SC Woolley","year":"2010","unstructured":"Woolley SC, Moore DH, Katz JS (2010) Insight in ALS: awareness of behavioral change in patients with and without FTD. Amyotroph Lateral Scler 11(1\u20132):52\u201356","journal-title":"Amyotroph Lateral Scler"},{"key":"4830_CR29","doi-asserted-by":"crossref","first-page":"679","DOI":"10.3389\/fnins.2020.00679","volume":"14","author":"ML Cali\u00f3","year":"2020","unstructured":"Cali\u00f3 ML, Henriques E, Siena A, Bertoncini CRA, Gil-Mohapel J, Rosenstock TR (2020) Mitochondrial dysfunction, neurogenesis, and epigenetics: putative implications for amyotrophic lateral sclerosis neurodegeneration and treatment. Front Neurosci 14:679","journal-title":"Front Neurosci"},{"issue":"13","key":"4830_CR30","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.3390\/cells11132049","volume":"11","author":"J Zhao","year":"2022","unstructured":"Zhao J, Wang X, Huo Z, Chen Y, Liu J, Zhao Z et al (2022) The impact of mitochondrial dysfunction in amyotrophic lateral sclerosis. Cells 11(13):2049","journal-title":"Cells"},{"key":"4830_CR31","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3389\/fncel.2014.00147","volume":"8","author":"V Tadic","year":"2014","unstructured":"Tadic V, Prell T, Lautenschlaeger J, Grosskreutz J (2014) The ER mitochondria calcium cycle and ER stress response as therapeutic targets in amyotrophic lateral sclerosis. Front Cell Neurosci 8:147","journal-title":"Front Cell Neurosci"},{"key":"4830_CR32","first-page":"199","volume":"7","author":"MK Jaiswal","year":"2013","unstructured":"Jaiswal MK (2013) Calcium, mitochondria, and the pathogenesis of ALS: the good, the bad, and the ugly. Front Media SA 7:199","journal-title":"Front Media SA"},{"issue":"3","key":"4830_CR33","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3390\/metabo12030233","volume":"12","author":"N Candelise","year":"2022","unstructured":"Candelise N, Salvatori I, Scaricamazza S, Nesci V, Zenuni H, Ferri A et al (2022) Mechanistic insights of mitochondrial dysfunction in amyotrophic lateral sclerosis: an update on a lasting relationship. Metabolites 12(3):233","journal-title":"Metabolites"},{"key":"4830_CR34","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.brainres.2014.09.065","volume":"1607","author":"GM Palomo","year":"2015","unstructured":"Palomo GM, Manfredi G (2015) Exploring new pathways of neurodegeneration in ALS: the role of mitochondria quality control. Brain Res 1607:36\u201346","journal-title":"Brain Res"},{"issue":"1","key":"4830_CR35","doi-asserted-by":"crossref","first-page":"4356","DOI":"10.1038\/s41467-023-40043-0","volume":"14","author":"L Rios","year":"2023","unstructured":"Rios L, Pokhrel S, Li S-J, Heo G, Haileselassie B, Mochly-Rosen D (2023) Targeting an allosteric site in dynamin-related protein 1 to inhibit Fis1-mediated mitochondrial dysfunction. Nat Commun 14(1):4356","journal-title":"Nat Commun"},{"issue":"1","key":"4830_CR36","doi-asserted-by":"crossref","first-page":"14034","DOI":"10.1038\/s41598-018-32228-1","volume":"8","author":"OS Kornfeld","year":"2018","unstructured":"Kornfeld OS, Qvit N, Haileselassie B, Shamloo M, Bernardi P, Mochly-Rosen D (2018) Interaction of mitochondrial fission factor with dynamin related protein 1 governs physiological mitochondrial function in vivo. Sci Rep 8(1):14034","journal-title":"Sci Rep"},{"issue":"1","key":"4830_CR37","doi-asserted-by":"crossref","first-page":"17593","DOI":"10.1038\/s41598-019-53009-4","volume":"9","author":"J Blicher","year":"2019","unstructured":"Blicher J, Eskildsen S, St\u00e6rmose T, M\u00f8ller A, Figlewski K, Near J (2019) Short echo-time magnetic resonance spectroscopy in ALS, simultaneous quantification of glutamate and GABA at 3 T. Sci Rep 9(1):17593","journal-title":"Sci Rep"},{"issue":"5","key":"4830_CR38","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1093\/brain\/awac470","volume":"146","author":"L Chapman","year":"2023","unstructured":"Chapman L, Cooper-Knock J, Shaw PJ (2023) Physical activity as an exogenous risk factor for amyotrophic lateral sclerosis: a review of the evidence. Brain 146(5):1745\u20131757","journal-title":"Brain"},{"issue":"34","key":"4830_CR39","doi-asserted-by":"crossref","first-page":"8774","DOI":"10.1523\/JNEUROSCI.2315-06.2006","volume":"26","author":"TW Gould","year":"2006","unstructured":"Gould TW, Buss RR, Vinsant S, Prevette D, Sun W, Knudson CM et al (2006) Complete dissociation of motor neuron death from motor dysfunction by Bax deletion in a mouse model of ALS. J Neurosci 26(34):8774\u20138786","journal-title":"J Neurosci"},{"key":"4830_CR40","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3389\/fncel.2018.00015","volume":"12","author":"N Duval","year":"2018","unstructured":"Duval N, Sumner WA, Andrianakos AG, Gray JJ, Bouchard RJ, Wilkins HM et al (2018) The Bcl-2 homology-3 domain (BH3)-only proteins, Bid, DP5\/Hrk, and BNip3L, are upregulated in reactive astrocytes of end-stage mutant SOD1 mouse spinal cord. Front Cell Neurosci 12:15","journal-title":"Front Cell Neurosci"},{"issue":"12","key":"4830_CR41","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1038\/sj.cdd.4401943","volume":"13","author":"C Crosio","year":"2006","unstructured":"Crosio C, Casciati A, Iaccarino C, Rotilio G, Carr\u00ec MT (2006) Bcl2a1 serves as a switch in death of motor neurons in amyotrophic lateral sclerosis. Cell Death Differ 13(12):2150\u20132153","journal-title":"Cell Death Differ"},{"issue":"12","key":"4830_CR42","doi-asserted-by":"crossref","first-page":"3526","DOI":"10.1093\/brain\/awaa309","volume":"143","author":"BE Clarke","year":"2020","unstructured":"Clarke BE, Patani R (2020) The microglial component of amyotrophic lateral sclerosis. Brain 143(12):3526\u20133539","journal-title":"Brain"},{"key":"4830_CR43","doi-asserted-by":"crossref","first-page":"242","DOI":"10.3389\/fnagi.2017.00242","volume":"9","author":"MC Geloso","year":"2017","unstructured":"Geloso MC, Corvino V, Marchese E, Serrano A, Michetti F, D\u2019Ambrosi N (2017) The dual role of microglia in ALS: mechanisms and therapeutic approaches. Front Aging Neurosci 9:242","journal-title":"Front Aging Neurosci"},{"issue":"7","key":"4830_CR44","doi-asserted-by":"crossref","first-page":"3782","DOI":"10.3390\/ijms25073782","volume":"25","author":"A Mo\u021b\u0103\u021b\u0103ianu","year":"2024","unstructured":"Mo\u021b\u0103\u021b\u0103ianu A, Andone S, Stoian A, B\u0103la\u0219a R, Hu\u021banu A, S\u0103rm\u0103\u0219an E (2024) A potential role of interleukin-5 in the pathogenesis and progression of amyotrophic lateral sclerosis: a new molecular perspective. Int J Mol Sci 25(7):3782","journal-title":"Int J Mol Sci"},{"key":"4830_CR45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cyto.2016.09.022","volume":"90","author":"HR Mart\u00ednez","year":"2017","unstructured":"Mart\u00ednez HR, Escamilla-Oca\u00f1as CE, Tenorio-Pedraza JM, G\u00f3mez-Almaguer D, Jaime-Perez JC, Olgu\u00edn-Ram\u00edrez LA et al (2017) Altered CSF cytokine network in amyotrophic lateral sclerosis patients: a pathway-based statistical analysis. Cytokine 90:1\u20135","journal-title":"Cytokine"},{"issue":"1","key":"4830_CR46","doi-asserted-by":"crossref","first-page":"19796","DOI":"10.1038\/s41598-024-67165-9","volume":"14","author":"C Femiano","year":"2024","unstructured":"Femiano C, Bruno A, Gilio L, Buttari F, Dolcetti E, Galifi G et al (2024) Inflammatory signature in amyotrophic lateral sclerosis predicting disease progression. Sci Rep 14(1):19796","journal-title":"Sci Rep"},{"issue":"1","key":"4830_CR47","doi-asserted-by":"crossref","first-page":"9094","DOI":"10.1038\/s41598-017-09097-1","volume":"7","author":"Y Hu","year":"2017","unstructured":"Hu Y, Cao C, Qin X-Y, Yu Y, Yuan J, Zhao Y et al (2017) Increased peripheral blood inflammatory cytokine levels in amyotrophic lateral sclerosis: a meta-analysis study. Sci Rep 7(1):9094","journal-title":"Sci Rep"},{"issue":"1","key":"4830_CR48","first-page":"5021694","volume":"2020","author":"T Cunha-Oliveira","year":"2020","unstructured":"Cunha-Oliveira T, Montezinho L, Mendes C, Firuzi O, Saso L, Oliveira PJ et al (2020) Oxidative stress in amyotrophic lateral sclerosis: pathophysiology and opportunities for pharmacological intervention. Oxid Med Cell Longev 2020(1):5021694","journal-title":"Oxid Med Cell Longev"},{"issue":"9","key":"4830_CR49","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.3390\/pr9091667","volume":"9","author":"T Hosaka","year":"2021","unstructured":"Hosaka T, Tsuji H, Tamaoka A (2021) Biomolecular modifications linked to oxidative stress in amyotrophic lateral sclerosis: determining promising biomarkers related to oxidative stress. Processes 9(9):1667","journal-title":"Processes"},{"issue":"9","key":"4830_CR50","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.3390\/diagnostics11091546","volume":"11","author":"HR Park","year":"2021","unstructured":"Park HR, Yang EJ (2021) Oxidative stress as a therapeutic target in amyotrophic lateral sclerosis: opportunities and limitations. Diagnostics 11(9):1546","journal-title":"Diagnostics"},{"key":"4830_CR51","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2020.581950","volume":"14","author":"CJ Jagaraj","year":"2021","unstructured":"Jagaraj CJ, Parakh S, Atkin JD (2021) Emerging evidence highlighting the importance of redox dysregulation in the pathogenesis of amyotrophic lateral sclerosis (ALS). Front Cell Neurosci 14:581950","journal-title":"Front Cell Neurosci"},{"issue":"6","key":"4830_CR52","first-page":"5799","volume":"18","author":"B Liu","year":"2018","unstructured":"Liu B, Jiang T, Hu X, Liu Z, Zhao L, Liu H et al (2018) Downregulation of microRNA-30a in bronchoalveolar lavage fluid from idiopathic pulmonary fibrosis patients. Mol Med Rep 18(6):5799\u20135806","journal-title":"Mol Med Rep"},{"issue":"7","key":"4830_CR53","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1038\/labinvest.2013.73","volume":"93","author":"Y Guo","year":"2013","unstructured":"Guo Y, Zhang Y, Wen D, Duan W, An T, Shi P et al (2013) The modest impact of transcription factor Nrf2 on the course of disease in an ALS animal model. Lab Invest 93(7):825\u2013833","journal-title":"Lab Invest"},{"issue":"5","key":"4830_CR54","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.3390\/molecules27051471","volume":"27","author":"L Arslanbaeva","year":"2022","unstructured":"Arslanbaeva L, Bisaglia M (2022) Activation of the Nrf2 pathway as a therapeutic strategy for ALS treatment. Molecules 27(5):1471","journal-title":"Molecules"},{"issue":"8","key":"4830_CR55","volume":"12","author":"MD de Carvalho Vilar","year":"2022","unstructured":"de Carvalho Vilar MD, Coutinho KMD, de Lima Vale SH, Medeiros GCBS, Piuvezam G, Leite-Lais L et al (2022) Nutritional therapy in amyotrophic lateral sclerosis: protocol for a systematic review and meta-analysis. BMJ Open 12(8):e064086","journal-title":"BMJ Open"},{"issue":"10","key":"4830_CR56","doi-asserted-by":"crossref","first-page":"4729","DOI":"10.1007\/s00415-023-11838-4","volume":"270","author":"Q Zhu","year":"2023","unstructured":"Zhu Q, Xu D, Huang H, Li D, Yang D, Zhou J et al (2023) The safety and effectiveness of high-calorie therapy for treating amyotrophic lateral sclerosis: a systematic review and meta-analysis. J Neurol 270(10):4729\u20134743","journal-title":"J Neurol"},{"issue":"2","key":"4830_CR57","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/ana.25661","volume":"87","author":"AC Ludolph","year":"2020","unstructured":"Ludolph AC, Dorst J, Dreyhaupt J, Weishaupt JH, Kassubek J, Weiland U et al (2020) Effect of high-caloric nutrition on survival in amyotrophic lateral sclerosis. Ann Neurol 87(2):206\u2013216","journal-title":"Ann Neurol"},{"issue":"2","key":"4830_CR58","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1080\/14660820410020349","volume":"5","author":"C Heffernan","year":"2004","unstructured":"Heffernan C, Jenkinson C, Holmes T, Feder G, Kupfer R, Leigh PN et al (2004) Nutritional management in MND\/ALS patients: an evidence based review. Amyotroph Lateral Scler Other Motor Neuron Disord 5(2):72\u201383","journal-title":"Amyotroph Lateral Scler Other Motor Neuron Disord"},{"issue":"1\u20132","key":"4830_CR59","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1080\/21678421.2017.1360355","volume":"19","author":"J Kellogg","year":"2018","unstructured":"Kellogg J, Bottman L, Arra EJ, Selkirk SM, Kozlowski F (2018) Nutrition management methods effective in increasing weight, survival time and functional status in ALS patients: a systematic review. Amyotroph Lateral Scler Frontotemporal Degener 19(1\u20132):7\u201311","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"issue":"23","key":"4830_CR60","doi-asserted-by":"crossref","first-page":"5074","DOI":"10.3390\/nu14235074","volume":"14","author":"K Imdad","year":"2022","unstructured":"Imdad K, Abualait T, Kanwal A, AlGhannam ZT, Bashir S, Farrukh A et al (2022) The metabolic role of ketogenic diets in treating epilepsy. Nutrients 14(23):5074","journal-title":"Nutrients"},{"issue":"10","key":"4830_CR61","doi-asserted-by":"crossref","first-page":"699","DOI":"10.6061\/clinics\/2014(10)09","volume":"69","author":"PAD Lima","year":"2014","unstructured":"Lima PAD, Sampaio LPDB, Damasceno NRT (2014) Neurobiochemical mechanisms of a ketogenic diet in refractory epilepsy. Clinics 69(10):699\u2013705","journal-title":"Clinics"},{"key":"4830_CR62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00726-016-2336-7","volume":"49","author":"RM Clanton","year":"2017","unstructured":"Clanton RM, Wu G, Akabani G, Aramayo R (2017) Control of seizures by ketogenic diet-induced modulation of metabolic pathways. Amino Acids 49:1\u201320","journal-title":"Amino Acids"},{"key":"4830_CR63","doi-asserted-by":"crossref","unstructured":"Nikdasti A, Khodadadi ES, Ferdosi F, Dadgostar E, Yahyazadeh S, Heidari P, Ehtiati S, Vakili O, Khatami SH (2024) Nutritional strategies in major depression disorder: From Ketogenic Diet to Modulation of the Microbiota-Gut-Brain Axis.\u00a0Mol Neurobiol 28:1\u201322","DOI":"10.1007\/s12035-024-04446-4"},{"issue":"23","key":"4830_CR64","doi-asserted-by":"crossref","first-page":"5003","DOI":"10.3390\/nu14235003","volume":"14","author":"D Dy\u0144ka","year":"2022","unstructured":"Dy\u0144ka D, Kowalcze K, Paziewska A (2022) The role of ketogenic diet in the treatment of neurological diseases. Nutrients 14(23):5003","journal-title":"Nutrients"},{"issue":"8","key":"4830_CR65","doi-asserted-by":"crossref","first-page":"148","DOI":"10.3390\/brainsci8080148","volume":"8","author":"TJ McDonald","year":"2018","unstructured":"McDonald TJ, Cervenka MC (2018) The expanding role of ketogenic diets in adult neurological disorders. Brain Sci 8(8):148","journal-title":"Brain Sci"},{"issue":"1","key":"4830_CR66","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s42494-024-00150-x","volume":"6","author":"H Li","year":"2024","unstructured":"Li H, Wang Y, Guo J, Zhang P, Xu Z, Peng K et al (2024) Efficacy and safety of modified medium-chain triglyceride ketogenic diet in patients with drug-resistant epilepsy. Acta Epileptologica 6(1):9","journal-title":"Acta Epileptologica"},{"issue":"1","key":"4830_CR67","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4103\/2319-4170.107154","volume":"36","author":"Y-M Liu","year":"2013","unstructured":"Liu Y-M, Wang H-S (2013) Medium-chain triglyceride ketogenic diet, an effective treatment for drug-resistant epilepsy and a comparison with other ketogenic diets. Biomed j 36(1):9\u201315","journal-title":"Biomed j"},{"issue":"3","key":"4830_CR68","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/01.nrl.0000160818.58821.d2","volume":"11","author":"SR Sinha","year":"2005","unstructured":"Sinha SR, Kossoff EH (2005) The ketogenic diet. Neurologist 11(3):161\u2013170","journal-title":"Neurologist"},{"issue":"2","key":"4830_CR69","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.eplepsyres.2005.10.003","volume":"68","author":"J Freeman","year":"2006","unstructured":"Freeman J, Veggiotti P, Lanzi G, Tagliabue A, Perucca E (2006) The ketogenic diet: from molecular mechanisms to clinical effects. Epilepsy Res 68(2):145\u2013180","journal-title":"Epilepsy Res"},{"issue":"1","key":"4830_CR70","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41392-021-00831-w","volume":"7","author":"H Zhu","year":"2022","unstructured":"Zhu H, Bi D, Zhang Y, Kong C, Du J, Wu X et al (2022) Ketogenic diet for human diseases: the underlying mechanisms and potential for clinical implementations. Signal Transduct Target Ther 7(1):11","journal-title":"Signal Transduct Target Ther"},{"key":"4830_CR71","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1528-1167.2008.01832.x","volume":"49","author":"HH Pfeifer","year":"2008","unstructured":"Pfeifer HH, Lyczkowski DA, Thiele EA (2008) Low glycemic index treatment: implementation and new insights into efficacy. Epilepsia 49:42\u201345","journal-title":"Epilepsia"},{"issue":"1","key":"4830_CR72","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/s41420-023-01549-0","volume":"9","author":"W Zhang","year":"2023","unstructured":"Zhang W, Chen S, Huang X, Tong H, Niu H, Lu L (2023) Neuroprotective effect of a medium-chain triglyceride ketogenic diet on MPTP-induced Parkinson\u2019s disease mice: a combination of transcriptomics and metabolomics in the substantia nigra and fecal microbiome. Cell Death Discov 9(1):251","journal-title":"Cell Death Discov"},{"key":"4830_CR73","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3389\/fphar.2012.00059","volume":"3","author":"CE Stafstrom","year":"2012","unstructured":"Stafstrom CE, Rho JM (2012) The ketogenic diet as a treatment paradigm for diverse neurological disorders. Front Pharmacol 3:59","journal-title":"Front Pharmacol"},{"issue":"1","key":"4830_CR74","doi-asserted-by":"crossref","first-page":"124","DOI":"10.3390\/ijms25010124","volume":"25","author":"J Jang","year":"2023","unstructured":"Jang J, Kim SR, Lee JE, Lee S, Son HJ, Choe W et al (2023) Molecular mechanisms of neuroprotection by ketone bodies and ketogenic diet in cerebral ischemia and neurodegenerative diseases. Int J Mol Sci 25(1):124","journal-title":"Int J Mol Sci"},{"key":"4830_CR75","doi-asserted-by":"crossref","first-page":"585","DOI":"10.3389\/fneur.2019.00585","volume":"10","author":"H Yang","year":"2019","unstructured":"Yang H, Shan W, Zhu F, Wu J, Wang Q (2019) Ketone bodies in neurological diseases: focus on neuroprotection and underlying mechanisms. Front Neurol 10:585","journal-title":"Front Neurol"},{"issue":"28","key":"4830_CR76","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1038\/s41388-024-03076-3","volume":"43","author":"GA Metcalf","year":"2024","unstructured":"Metcalf GA (2024) MicroRNAs: circulating biomarkers for the early detection of imperceptible cancers via biosensor and machine-learning advances. Oncogene 43(28):2135\u20132142","journal-title":"Oncogene"},{"issue":"10","key":"4830_CR77","doi-asserted-by":"crossref","first-page":"3566","DOI":"10.1158\/0008-5472.CAN-07-6639","volume":"68","author":"B Kefas","year":"2008","unstructured":"Kefas B, Godlewski J, Comeau L, Li Y, Abounader R, Hawkinson M et al (2008) microRNA-7 inhibits the epidermal growth factor receptor and the Akt pathway and is down-regulated in glioblastoma. Can Res 68(10):3566\u20133572","journal-title":"Can Res"},{"issue":"2","key":"4830_CR78","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/WCO.0000000000000432","volume":"30","author":"D Boison","year":"2017","unstructured":"Boison D (2017) New insights into the mechanisms of the ketogenic diet. Curr Opin Neurol 30(2):187\u2013192","journal-title":"Curr Opin Neurol"},{"key":"4830_CR79","doi-asserted-by":"crossref","first-page":"1297984","DOI":"10.3389\/fnins.2023.1297984","volume":"17","author":"M Ramezani","year":"2023","unstructured":"Ramezani M, Fernando M, Eslick S, Asih PR, Shadfar S, Bandara EM et al (2023) Ketone bodies mediate alterations in brain energy metabolism and biomarkers of Alzheimer\u2019s disease. Front Neurosci 17:1297984","journal-title":"Front Neurosci"},{"issue":"22","key":"4830_CR80","doi-asserted-by":"crossref","first-page":"8767","DOI":"10.3390\/ijms21228767","volume":"21","author":"NJ Jensen","year":"2020","unstructured":"Jensen NJ, Wodschow HZ, Nilsson M, Rungby J (2020) Effects of ketone bodies on brain metabolism and function in neurodegenerative diseases. Int J Mol Sci 21(22):8767","journal-title":"Int J Mol Sci"},{"key":"4830_CR81","doi-asserted-by":"crossref","first-page":"1214092","DOI":"10.3389\/fnmol.2023.1214092","volume":"16","author":"L Garc\u00eda-Vel\u00e1zquez","year":"2023","unstructured":"Garc\u00eda-Vel\u00e1zquez L, Massieu L (2023) The proteomic effects of ketone bodies: implications for proteostasis and brain proteinopathies. Front Mol Neurosci 16:1214092","journal-title":"Front Mol Neurosci"},{"key":"4830_CR82","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-016-0525-7","volume":"13","author":"D Heras-Sandoval","year":"2016","unstructured":"Heras-Sandoval D, Pedraza-Chaverri J, P\u00e9rez-Rojas JM (2016) Role of docosahexaenoic acid in the modulation of glial cells in Alzheimer\u2019s disease. J Neuroinflammation 13:1\u201313","journal-title":"J Neuroinflammation"},{"issue":"10","key":"4830_CR83","doi-asserted-by":"crossref","first-page":"5390","DOI":"10.3390\/ijms23105390","volume":"23","author":"AB Petermann","year":"2022","unstructured":"Petermann AB, Reyna-Jeldes M, Ortega L, Coddou C, Y\u00e9venes GE (2022) Roles of the unsaturated fatty acid docosahexaenoic acid in the central nervous system: molecular and cellular insights. Int J Mol Sci 23(10):5390","journal-title":"Int J Mol Sci"},{"issue":"3","key":"4830_CR84","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/nm.3804","volume":"21","author":"Y-H Youm","year":"2015","unstructured":"Youm Y-H, Nguyen KY, Grant RW, Goldberg EL, Bodogai M, Kim D et al (2015) The ketone metabolite \u03b2-hydroxybutyrate blocks NLRP3 inflammasome\u2013mediated inflammatory disease. Nat Med 21(3):263\u2013269","journal-title":"Nat Med"},{"issue":"1","key":"4830_CR85","doi-asserted-by":"crossref","first-page":"7677","DOI":"10.1038\/s41598-017-08055-1","volume":"7","author":"T Yamanashi","year":"2017","unstructured":"Yamanashi T, Iwata M, Kamiya N, Tsunetomi K, Kajitani N, Wada N et al (2017) Beta-hydroxybutyrate, an endogenic NLRP3 inflammasome inhibitor, attenuates stress-induced behavioral and inflammatory responses. Sci Rep 7(1):7677","journal-title":"Sci Rep"},{"issue":"1","key":"4830_CR86","doi-asserted-by":"crossref","first-page":"21629","DOI":"10.1038\/s41598-020-78410-2","volume":"10","author":"T Yamanashi","year":"2020","unstructured":"Yamanashi T, Iwata M, Shibushita M, Tsunetomi K, Nagata M, Kajitani N et al (2020) Beta-hydroxybutyrate, an endogenous NLRP3 inflammasome inhibitor, attenuates anxiety-related behavior in a rodent post-traumatic stress disorder model. Sci Rep 10(1):21629","journal-title":"Sci Rep"},{"key":"4830_CR87","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.880544","volume":"10","author":"S Dash","year":"2022","unstructured":"Dash S, Syed YA, Khan MR (2022) Understanding the role of the gut microbiome in brain development and its association with neurodevelopmental psychiatric disorders. Front Cell Dev Biol 10:880544","journal-title":"Front Cell Dev Biol"},{"issue":"4","key":"4830_CR88","first-page":"326","volume":"15","author":"L Rew","year":"2022","unstructured":"Rew L, Harris MD, Goldie J (2022) The ketogenic diet: its impact on human gut microbiota and potential consequent health outcomes: a systematic literature review. Gastroenterol Hepatol Bed Bench 15(4):326","journal-title":"Gastroenterol Hepatol Bed Bench"},{"issue":"17","key":"4830_CR89","doi-asserted-by":"crossref","first-page":"3680","DOI":"10.3390\/nu15173680","volume":"15","author":"A Santangelo","year":"2023","unstructured":"Santangelo A, Corsello A, Spolidoro GCI, Trovato CM, Agostoni C, Orsini A et al (2023) The influence of ketogenic diet on gut microbiota: potential benefits, risks and indications. Nutrients 15(17):3680","journal-title":"Nutrients"},{"issue":"1","key":"4830_CR90","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3390\/nu13010007","volume":"13","author":"G Merra","year":"2020","unstructured":"Merra G, Noce A, Marrone G, Cintoni M, Tarsitano MG, Capacci A et al (2020) Influence of mediterranean diet on human gut microbiota. Nutrients 13(1):7","journal-title":"Nutrients"},{"issue":"23","key":"4830_CR91","doi-asserted-by":"crossref","first-page":"4201","DOI":"10.3390\/nu16234201","volume":"16","author":"S Deleu","year":"2024","unstructured":"Deleu S, Becherucci G, Godny L, Mentella MC, Petito V, Scaldaferri F (2024) The key nutrients in the mediterranean diet and their effects in inflammatory bowel disease: a narrative review. Nutrients 16(23):4201","journal-title":"Nutrients"},{"key":"4830_CR92","doi-asserted-by":"crossref","first-page":"1197759","DOI":"10.3389\/fnins.2023.1197759","volume":"17","author":"V Mansuy-Aubert","year":"2023","unstructured":"Mansuy-Aubert V, Ravussin Y (2023) Short chain fatty acids: the messengers from down below. Front Neurosci 17:1197759","journal-title":"Front Neurosci"},{"issue":"8","key":"4830_CR93","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/s41575-019-0157-3","volume":"16","author":"B Dalile","year":"2019","unstructured":"Dalile B, Van Oudenhove L, Vervliet B, Verbeke K (2019) The role of short-chain fatty acids in microbiota\u2013gut\u2013brain communication. Nat Rev Gastroenterol Hepatol 16(8):461\u2013478","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"4830_CR94","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41522-018-0073-2","volume":"5","author":"M Lindefeldt","year":"2019","unstructured":"Lindefeldt M, Eng A, Darban H, Bjerkner A, Zetterstr\u00f6m CK, Allander T et al (2019) The ketogenic diet influences taxonomic and functional composition of the gut microbiota in children with severe epilepsy. npj Biofilms Microbiomes 5(1):5","journal-title":"npj Biofilms Microbiomes"},{"key":"4830_CR95","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.ebiom.2019.08.032","volume":"47","author":"R Nagpal","year":"2019","unstructured":"Nagpal R, Neth BJ, Wang S, Craft S, Yadav H (2019) Modified Mediterranean-ketogenic diet modulates gut microbiome and short-chain fatty acids in association with Alzheimer\u2019s disease markers in subjects with mild cognitive impairment. EBioMedicine 47:529\u2013542","journal-title":"EBioMedicine"},{"key":"4830_CR96","doi-asserted-by":"crossref","unstructured":"Neth BJ, Huynh K, Giles C, Wang T, Mellett NA, Duong T, Blach C, Schimmel L, Register TC, Blennow K, Zetterberg H (2023) Therapeutic potential of a modified Mediterranean ketogenic diet in reversing the peripheral lipid signature of Alzheimer\u2019s disease. medRxiv 20:2023\u201306","DOI":"10.1101\/2023.06.13.23291049"},{"key":"4830_CR97","volume":"62","author":"E Rinninella","year":"2023","unstructured":"Rinninella E, Tohumcu E, Raoul P, Fiorani M, Cintoni M, Mele MC et al (2023) The role of diet in shaping human gut microbiota. Best Pract Res Clin Gastroenterol 62:101828","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"4830_CR98","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2202-7-1","volume":"7","author":"Z Zhao","year":"2006","unstructured":"Zhao Z, Lange DJ, Voustianiouk A, MacGrogan D, Ho L, Suh J et al (2006) A ketogenic diet as a potential novel therapeutic intervention in amyotrophic lateral sclerosis. BMC Neurosci 7:1\u201310","journal-title":"BMC Neurosci"},{"issue":"7","key":"4830_CR99","volume":"9","author":"C Ari","year":"2014","unstructured":"Ari C, Poff AM, Held HE, Landon CS, Goldhagen CR, Mavromates N et al (2014) Metabolic therapy with Deanna Protocol supplementation delays disease progression and extends survival in amyotrophic lateral sclerosis (ALS) mouse model. PLoS ONE 9(7):e103526","journal-title":"PLoS ONE"},{"issue":"8","key":"4830_CR100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0161816","volume":"11","author":"TW Tefera","year":"2016","unstructured":"Tefera TW, Wong Y, Barkl-Luke ME, Ngo ST, Thomas NK, McDonald TS et al (2016) Triheptanoin protects motor neurons and delays the onset of motor symptoms in a mouse model of amyotrophic lateral sclerosis. PLoS ONE 11(8):e0161816","journal-title":"PLoS ONE"},{"issue":"11","key":"4830_CR101","volume":"7","author":"W Zhao","year":"2012","unstructured":"Zhao W, Varghese M, Vempati P, Dzhun A, Cheng A, Wang J et al (2012) Caprylic triglyceride as a novel therapeutic approach to effectively improve the performance and attenuate the symptoms due to the motor neuron loss in ALS disease. PLoS ONE 7(11):e49191","journal-title":"PLoS ONE"},{"issue":"18","key":"4830_CR102","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1089\/neu.2017.5192","volume":"34","author":"G Kong","year":"2017","unstructured":"Kong G, Huang Z, Ji W, Wang X, Liu J, Wu X et al (2017) The ketone metabolite \u03b2-hydroxybutyrate attenuates oxidative stress in spinal cord injury by suppression of class I histone deacetylases. J Neurotrauma 34(18):2645\u20132655","journal-title":"J Neurotrauma"},{"issue":"5","key":"4830_CR103","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/iub.1627","volume":"69","author":"RL Veech","year":"2017","unstructured":"Veech RL, Bradshaw PC, Clarke K, Curtis W, Pawlosky R, King MT (2017) Ketone bodies mimic the life span extending properties of caloric restriction. IUBMB Life 69(5):305\u2013314","journal-title":"IUBMB Life"},{"issue":"9","key":"4830_CR104","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1089\/neu.2011.1822","volume":"28","author":"Y Deng-Bryant","year":"2011","unstructured":"Deng-Bryant Y, Prins ML, Hovda DA, Harris NG (2011) Ketogenic diet prevents alterations in brain metabolism in young but not adult rats after traumatic brain injury. J Neurotrauma 28(9):1813\u20131825","journal-title":"J Neurotrauma"},{"key":"4830_CR105","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.neubiorev.2017.02.001","volume":"75","author":"M Mamelak","year":"2017","unstructured":"Mamelak M (2017) Energy and the Alzheimer brain. Neurosci Biobehav Rev 75:297\u2013313","journal-title":"Neurosci Biobehav Rev"},{"issue":"1\u20132","key":"4830_CR106","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.exger.2006.06.002","volume":"42","author":"M Steele","year":"2007","unstructured":"Steele M, Stuchbury G, M\u00fcnch G (2007) The molecular basis of the prevention of Alzheimer\u2019s disease through healthy nutrition. Exp Gerontol 42(1\u20132):28\u201336","journal-title":"Exp Gerontol"},{"issue":"6","key":"4830_CR107","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1172\/JCI200318797","volume":"112","author":"K Tieu","year":"2003","unstructured":"Tieu K, Perier C, Caspersen C, Teismann P, Wu D-C, Yan S-D et al (2003) D-\u03b2-Hydroxybutyrate rescues mitochondrial respiration and mitigates features of Parkinson disease. J Clin Investig 112(6):892\u2013901","journal-title":"J Clin Investig"},{"issue":"6","key":"4830_CR108","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1111\/j.1460-9568.2007.05415.x","volume":"25","author":"HG Niessen","year":"2007","unstructured":"Niessen HG, Debska-Vielhaber G, Sander K, Angenstein F, Ludolph AC, Hilfert L et al (2007) Metabolic progression markers of neurodegeneration in the transgenic G93A-SOD1 mouse model of amyotrophic lateral sclerosis. Eur J Neurosci 25(6):1669\u20131677","journal-title":"Eur J Neurosci"},{"issue":"3","key":"4830_CR109","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1159\/000338048","volume":"11","author":"S K\u00f6rner","year":"2013","unstructured":"K\u00f6rner S, B\u00f6selt S, Thau N, Rath KJ, Dengler R, Petri S (2013) Differential sirtuin expression patterns in amyotrophic lateral sclerosis (ALS) postmortem tissue: neuroprotective or neurotoxic properties of sirtuins in ALS? Neurodegener Dis 11(3):141\u2013152","journal-title":"Neurodegener Dis"},{"key":"4830_CR110","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.nbd.2012.07.004","volume":"51","author":"W Song","year":"2013","unstructured":"Song W, Song Y, Kincaid B, Bossy B, Bossy-Wetzel E (2013) Mutant SOD1G93A triggers mitochondrial fragmentation in spinal cord motor neurons: neuroprotection by SIRT3 and PGC-1\u03b1. Neurobiol Dis 51:72\u201381","journal-title":"Neurobiol Dis"},{"issue":"1","key":"4830_CR111","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1006\/exnr.1999.7190","volume":"160","author":"II Kruman","year":"1999","unstructured":"Kruman II, Pedersen WA, Springer JE, Mattson MP (1999) ALS-linked Cu\/Zn\u2013SOD mutation increases vulnerability of motor neurons to excitotoxicity by a mechanism involving increased oxidative stress and perturbed calcium homeostasis. Exp Neurol 160(1):28\u201339","journal-title":"Exp Neurol"},{"issue":"1","key":"4830_CR112","doi-asserted-by":"crossref","first-page":"18916","DOI":"10.1038\/s41598-021-97928-7","volume":"11","author":"T Singh","year":"2021","unstructured":"Singh T, Jiao Y, Ferrando LM, Yablonska S, Li F, Horoszko EC et al (2021) Neuronal mitochondrial dysfunction in sporadic amyotrophic lateral sclerosis is developmentally regulated. Sci Rep 11(1):18916","journal-title":"Sci Rep"},{"issue":"3","key":"4830_CR113","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.plefa.2003.09.007","volume":"70","author":"RL Veech","year":"2004","unstructured":"Veech RL (2004) The therapeutic implications of ketone bodies: the effects of ketone bodies in pathological conditions: ketosis, ketogenic diet, redox states, insulin resistance, and mitochondrial metabolism. Prostaglandins Leukot Essent Fatty Acids 70(3):309\u2013319","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"4830_CR114","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2021.782657","volume":"8","author":"SM Gough","year":"2021","unstructured":"Gough SM, Casella A, Ortega KJ, Hackam AS (2021) Neuroprotection by the ketogenic diet: evidence and controversies. Front Nutr 8:782657","journal-title":"Front Nutr"},{"key":"4830_CR115","first-page":"1765","volume":"130","author":"L-P Yang","year":"2017","unstructured":"Yang L-P, Fan D-S (2017) Diets for patients with amyotrophic lateral sclerosis: pay attention to nutritional intervention. LWW 130:1765\u20137","journal-title":"LWW"},{"issue":"5","key":"4830_CR116","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1080\/17482960701472249","volume":"8","author":"K Okamoto","year":"2007","unstructured":"Okamoto K, Kihira T, Kondo T, Kobashi G, Washio M, Sasaki S et al (2007) Nutritional status and risk of amyotrophic lateral sclerosis in Japan. Amyotroph Lateral Scler 8(5):300\u2013304","journal-title":"Amyotroph Lateral Scler"},{"issue":"9934","key":"4830_CR117","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1016\/S0140-6736(14)60222-1","volume":"383","author":"A-M Wills","year":"2014","unstructured":"Wills A-M, Hubbard J, Macklin EA, Glass J, Tandan R, Simpson EP et al (2014) Hypercaloric enteral nutrition in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled phase 2 trial. The Lancet 383(9934):2065\u20132072","journal-title":"The Lancet"},{"issue":"12","key":"4830_CR118","doi-asserted-by":"crossref","first-page":"3128","DOI":"10.3390\/foods10123128","volume":"10","author":"S D\u2019Antona","year":"2021","unstructured":"D\u2019Antona S, Caramenti M, Porro D, Castiglioni I, Cava C (2021) Amyotrophic lateral sclerosis: a diet review. Foods 10(12):3128","journal-title":"Foods"},{"issue":"10","key":"4830_CR119","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1001\/jamaneurol.2015.1584","volume":"72","author":"MH Huisman","year":"2015","unstructured":"Huisman MH, Seelen M, van Doormaal PT, de Jong SW, de Vries JH, van der Kooi AJ et al (2015) Effect of presymptomatic body mass index and consumption of fat and alcohol on amyotrophic lateral sclerosis. JAMA Neurol 72(10):1155\u20131162","journal-title":"JAMA Neurol"},{"key":"4830_CR120","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2021.771047","volume":"8","author":"E Gangitano","year":"2021","unstructured":"Gangitano E, Tozzi R, Mariani S, Lenzi A, Gnessi L, Lubrano C (2021) Ketogenic diet for obese COVID-19 patients: is respiratory disease a contraindication? A narrative review of the literature on ketogenic diet and respiratory function. Front Nutr 8:771047","journal-title":"Front Nutr"},{"key":"4830_CR121","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.699427","volume":"8","author":"NG Norwitz","year":"2021","unstructured":"Norwitz NG, Winwood R, Stubbs BJ, D\u2019Agostino DP, Barnes PJ (2021) Case report: ketogenic diet is associated with improvements in chronic obstructive pulmonary disease. Front Med 8:699427","journal-title":"Front Med"},{"issue":"7\u20138","key":"4830_CR122","doi-asserted-by":"crossref","first-page":"533","DOI":"10.3109\/21678421.2013.823999","volume":"14","author":"J Dorst","year":"2013","unstructured":"Dorst J, Cypionka J, Ludolph AC (2013) High-caloric food supplements in the treatment of amyotrophic lateral sclerosis: a prospective interventional study. Amyotrop Lateral Scler Frontotemporal Degen 14(7\u20138):533\u2013536","journal-title":"Amyotrop Lateral Scler Frontotemporal Degen"},{"issue":"1","key":"4830_CR123","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/0300060514554725","volume":"43","author":"Z Zhao","year":"2015","unstructured":"Zhao Z, Sui Y, Gao W, Cai B, Fan D (2015) Effects of diet on adenosine monophosphate-activated protein kinase activity and disease progression in an amyotrophic lateral sclerosis model. J Int Med Res 43(1):67\u201379","journal-title":"J Int Med Res"},{"key":"4830_CR124","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1590\/S0004-282X2010000200021","volume":"68","author":"LBDC Silva","year":"2010","unstructured":"Silva LBDC, Mour\u00e3o LF, Silva AA, Lima NMFV, Almeida SR, Franca MC Jr et al (2010) Effect of nutritional supplementation with milk whey proteins in amyotrophic lateral sclerosis patients. Arquivos de Neuro-psiquiatria 68:263\u20138","journal-title":"Arquivos de Neuro-psiquiatria"},{"issue":"1","key":"4830_CR125","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/146608201300079364","volume":"2","author":"C Desnuelle","year":"2001","unstructured":"Desnuelle C, Dib M, Garrel C, Favier A (2001) A double-blind, placebo-controlled randomized clinical trial of \u03b1-tocopherol (vitamin E) in the treatment of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2(1):9\u201318","journal-title":"Amyotroph Lateral Scler Other Motor Neuron Disord"},{"key":"4830_CR126","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s00702-004-0220-1","volume":"112","author":"M Graf","year":"2005","unstructured":"Graf M, Ecker D, Horowski R, Kramer B, Riederer P, Gerlach M et al (2005) High dose vitamin E therapy in amyotrophic lateral sclerosis as add-on therapy to riluzole: results of a placebo-controlled double-blind study. J Neural Transm 112:649\u2013660","journal-title":"J Neural Transm"},{"issue":"6","key":"4830_CR127","doi-asserted-by":"crossref","first-page":"696","DOI":"10.3390\/metabo13060696","volume":"13","author":"ANDAB Barros","year":"2023","unstructured":"Barros ANDAB, Felipe MLDN, Barbosa IR, Leite-Lais L, Pedrosa LFC (2023) Dietary Intake of micronutrients and disease severity in patients with amyotrophic lateral sclerosis. Metabolites 13(6):696","journal-title":"Metabolites"},{"issue":"11","key":"4830_CR128","doi-asserted-by":"crossref","first-page":"3804","DOI":"10.3390\/nu13113804","volume":"13","author":"PS Goncharova","year":"2021","unstructured":"Goncharova PS, Davydova TK, Popova TE, Novitsky MA, Petrova MM, Gavrilyuk OA et al (2021) Nutrient effects on motor neurons and the risk of amyotrophic lateral sclerosis. Nutrients 13(11):3804","journal-title":"Nutrients"},{"issue":"31","key":"4830_CR129","doi-asserted-by":"crossref","first-page":"E2110","DOI":"10.1073\/pnas.1209414109","volume":"109","author":"M Fabbri","year":"2012","unstructured":"Fabbri M, Paone A, Calore F, Galli R, Gaudio E, Santhanam R et al (2012) MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response. Proc Natl Acad Sci 109(31):E2110\u2013E2116","journal-title":"Proc Natl Acad Sci"},{"key":"4830_CR130","doi-asserted-by":"crossref","first-page":"488","DOI":"10.3389\/fneur.2020.00488","volume":"11","author":"M Wang","year":"2020","unstructured":"Wang M, Liu Z, Sun W, Yuan Y, Jiao B, Zhang X et al (2020) Association between vitamins and amyotrophic lateral sclerosis: a center-based survey in mainland China. Front Neurol 11:488","journal-title":"Front Neurol"},{"issue":"11","key":"4830_CR131","doi-asserted-by":"crossref","first-page":"469","DOI":"10.3390\/biomedicines8110469","volume":"8","author":"S Mayengbam","year":"2020","unstructured":"Mayengbam S, Chleilat F, Reimer RA (2020) Dietary vitamin B6 deficiency impairs gut microbiota and host and microbial metabolites in rats. Biomedicines 8(11):469","journal-title":"Biomedicines"},{"key":"4830_CR132","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3389\/fnut.2019.00048","volume":"6","author":"K Yoshii","year":"2019","unstructured":"Yoshii K, Hosomi K, Sawane K, Kunisawa J (2019) Metabolism of dietary and microbial vitamin B family in the regulation of host immunity. Front Nutr 6:48","journal-title":"Front Nutr"},{"issue":"2","key":"4830_CR133","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/cei.12277","volume":"176","author":"N Serriari","year":"2014","unstructured":"Serriari N, Eoche M, Lamotte L, Lion J, Fumery M, Marcelo P et al (2014) Innate mucosal-associated invariant T (MAIT) cells are activated in inflammatory bowel diseases. Clin Exp Immunol 176(2):266\u2013274","journal-title":"Clin Exp Immunol"},{"issue":"7","key":"4830_CR134","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3390\/cells7070084","volume":"7","author":"M Parra","year":"2018","unstructured":"Parra M, Stahl S, Hellmann H (2018) Vitamin B6 and its role in cell metabolism and physiology. Cells 7(7):84","journal-title":"Cells"},{"issue":"3","key":"4830_CR135","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.pmr.2008.03.001","volume":"19","author":"J Rosenfeld","year":"2008","unstructured":"Rosenfeld J, Ellis A (2008) Nutrition and dietary supplements in motor neuron disease. Phys Med Rehabil Clin N Am 19(3):573\u2013589","journal-title":"Phys Med Rehabil Clin N Am"},{"issue":"3","key":"4830_CR136","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1212\/01.wnl.0000297193.53986.6f","volume":"70","author":"S Zoccolella","year":"2008","unstructured":"Zoccolella S, Simone IL, Lamberti P, Samarelli V, Tortelli R, Serlenga L et al (2008) Elevated plasma homocysteine levels in patients with amyotrophic lateral sclerosis. Neurology 70(3):222\u2013225","journal-title":"Neurology"},{"issue":"3","key":"4830_CR137","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1006\/bbrc.1999.0577","volume":"258","author":"VN Trieu","year":"1999","unstructured":"Trieu VN, Uckun FM (1999) Genistein is neuroprotective in murine models of familial amyotrophic lateral sclerosis and stroke. Biochem Biophys Res Commun 258(3):685\u2013688","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"4830_CR138","doi-asserted-by":"crossref","first-page":"C386","DOI":"10.1152\/ajpcell.00141.2016","volume":"311","author":"S Agrawal","year":"2016","unstructured":"Agrawal S, Agrawal A, Said HM (2016) Biotin deficiency enhances the inflammatory response of human dendritic cells. Am J Physiol Cell Physiol 311(3):C386\u2013C391","journal-title":"Am J Physiol Cell Physiol"},{"key":"4830_CR139","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s00018-012-1096-0","volume":"70","author":"L Tong","year":"2013","unstructured":"Tong L (2013) Structure and function of biotin-dependent carboxylases. Cell Mol Life Sci 70:863\u2013891","journal-title":"Cell Mol Life Sci"},{"issue":"19","key":"4830_CR140","doi-asserted-by":"crossref","first-page":"e01322","DOI":"10.1128\/AEM.01322-17","volume":"83","author":"M Ikeda","year":"2017","unstructured":"Ikeda M, Nagashima T, Nakamura E, Kato R, Ohshita M, Hayashi M et al (2017) In vivo roles of fatty acid biosynthesis enzymes in biosynthesis of biotin and \u03b1-lipoic acid in Corynebacterium glutamicum. Appl Environ Microbiol 83(19):e01322-e1417","journal-title":"Appl Environ Microbiol"},{"issue":"5","key":"4830_CR141","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2014-005213","volume":"4","author":"Y Riku","year":"2014","unstructured":"Riku Y, Atsuta N, Yoshida M, Tatsumi S, Iwasaki Y, Mimuro M et al (2014) Differential motor neuron involvement in progressive muscular atrophy: a comparative study with amyotrophic lateral sclerosis. BMJ Open 4(5):e005213","journal-title":"BMJ Open"},{"issue":"3","key":"4830_CR142","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1159\/000477397","volume":"24","author":"I Mangelsdorf","year":"2017","unstructured":"Mangelsdorf I, Walach H, Mutter J (2017) Healing of amyotrophic lateral sclerosis: a case report. Complementary Medicine Research 24(3):175\u2013181","journal-title":"Complementary Medicine Research"},{"key":"4830_CR143","doi-asserted-by":"crossref","unstructured":"Juntas-Morales R, Pageot N, Bendarraz A, Alphand\u00e9ry S, Sedel F, Seigle S, et al. (2020) High-dose pharmaceutical grade biotin (MD1003) in amyotrophic lateral sclerosis: a pilot study. EClinicalMedicine 19","DOI":"10.1016\/j.eclinm.2019.100254"},{"key":"4830_CR144","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s13594-016-0286-1","volume":"96","author":"A Homayouni Rad","year":"2016","unstructured":"Homayouni Rad A, Yari Khosroushahi A, Khalili M, Jafarzadeh S (2016) Folate bio-fortification of yoghurt and fermented milk: a review. Dairy Sci Technol 96:427\u2013441","journal-title":"Dairy Sci Technol"},{"issue":"2","key":"4830_CR145","doi-asserted-by":"crossref","first-page":"79","DOI":"10.5958\/2277-9396.2014.00008.7","volume":"4","author":"N Shah","year":"2014","unstructured":"Shah N, Patel A (2014) Recent advances in biosynthesis of vitamin and enzyme from food grade bacteria. Int J Food Ferment Technol 4(2):79\u201385","journal-title":"Int J Food Ferment Technol"},{"issue":"2","key":"4830_CR146","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1139\/bcb-2017-0069","volume":"96","author":"L Ojeda","year":"2018","unstructured":"Ojeda L, Nogales F, Murillo L, Carreras O (2018) The role of folic acid and selenium against oxidative damage from ethanol in early life programming: a review. Biochem Cell Biol 96(2):178\u2013188","journal-title":"Biochem Cell Biol"},{"issue":"1","key":"4830_CR147","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/ajcn\/nqaa293","volume":"113","author":"T Boumenna","year":"2021","unstructured":"Boumenna T, Scott TM, Lee J-S, Palacios N, Tucker KL (2021) Folate, vitamin B-12, and cognitive function in the Boston Puerto Rican Health Study. Am J Clin Nutr 113(1):179\u2013186","journal-title":"Am J Clin Nutr"},{"issue":"5","key":"4830_CR148","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/cga.12233","volume":"57","author":"S Ebara","year":"2017","unstructured":"Ebara S (2017) Nutritional role of folate. Congenit Anom 57(5):138\u2013141","journal-title":"Congenit Anom"},{"issue":"1\u20132","key":"4830_CR149","doi-asserted-by":"crossref","first-page":"140","DOI":"10.3109\/17482960902919360","volume":"11","author":"S Zoccolella","year":"2010","unstructured":"Zoccolella S, Bendotti C, Beghi E, Logroscino G (2010) Homocysteine levels and amyotrophic lateral sclerosis: a possible link. Amyotroph Lateral Scler 11(1\u20132):140\u2013147","journal-title":"Amyotroph Lateral Scler"},{"key":"4830_CR150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12934-017-0631-y","volume":"16","author":"H Fang","year":"2017","unstructured":"Fang H, Kang J, Zhang D (2017) Microbial production of vitamin B 12: a review and future perspectives. Microb Cell Fact 16:1\u201314","journal-title":"Microb Cell Fact"},{"issue":"19","key":"4830_CR151","first-page":"2603","volume":"129","author":"R Green","year":"2017","unstructured":"Green R (2017) Vitamin B12 deficiency from the perspective of a practicing hematologist. Blood, J Am Soc Hematol 129(19):2603\u20132611","journal-title":"Blood, J Am Soc Hematol"},{"issue":"10","key":"4830_CR152","first-page":"1141","volume":"59","author":"Y Izumi","year":"2007","unstructured":"Izumi Y, Kaji R (2007) Clinical trials of ultra-high-dose methylcobalamin in ALS. Brain and Nerve= Shinkei Kenkyu No Shinpo 59(10):1141\u20137","journal-title":"Brain and Nerve= Shinkei Kenkyu No Shinpo"},{"issue":"1\u20132","key":"4830_CR153","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jns.2010.02.024","volume":"293","author":"X Zhang","year":"2010","unstructured":"Zhang X, Chen S, Li L, Wang Q, Le W (2010) Decreased level of 5-methyltetrahydrofolate: a potential biomarker for pre-symptomatic amyotrophic lateral sclerosis. J Neurol Sci 293(1\u20132):102\u2013105","journal-title":"J Neurol Sci"},{"issue":"1\u20132","key":"4830_CR154","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jns.2015.04.052","volume":"354","author":"K Ikeda","year":"2015","unstructured":"Ikeda K, Iwasaki Y, Kaji R (2015) Neuroprotective effect of ultra-high dose methylcobalamin in wobbler mouse model of amyotrophic lateral sclerosis. J Neurol Sci 354(1\u20132):70\u201374","journal-title":"J Neurol Sci"},{"issue":"4","key":"4830_CR155","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1136\/jnnp-2018-319294","volume":"90","author":"R Kaji","year":"2019","unstructured":"Kaji R, Imai T, Iwasaki Y, Okamoto K, Nakagawa M, Ohashi Y et al (2019) Ultra-high-dose methylcobalamin in amyotrophic lateral sclerosis: a long-term phase II\/III randomised controlled study. J Neurol Neurosurg Psychiatry 90(4):451\u2013457","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"7","key":"4830_CR156","doi-asserted-by":"crossref","first-page":"659","DOI":"10.3390\/nu9070659","volume":"9","author":"J Kocot","year":"2017","unstructured":"Kocot J, Luchowska-Kocot D, Kie\u0142czykowska M, Musik I, Kurzepa J (2017) Does vitamin C influence neurodegenerative diseases and psychiatric disorders? Nutrients 9(7):659","journal-title":"Nutrients"},{"issue":"10","key":"4830_CR157","doi-asserted-by":"crossref","first-page":"e13223","DOI":"10.1371\/journal.pone.0013223","volume":"5","author":"H Blasco","year":"2010","unstructured":"Blasco H, Corcia P, Moreau C, Veau S, Fournier C, Vourc\u2019h P et al (2010) 1H-NMR-based metabolomic profiling of CSF in early amyotrophic lateral sclerosis. PloS one 5(10):e13223","journal-title":"PloS one"},{"issue":"3\u20134","key":"4830_CR158","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1080\/21678421.2017.1418002","volume":"19","author":"E Pupillo","year":"2018","unstructured":"Pupillo E, Bianchi E, Chi\u00f2 A, Casale F, Zecca C, Tortelli R et al (2018) Amyotrophic lateral sclerosis and food intake. Amyotrop Lat Sclerosis Frontotemporal Degen 19(3\u20134):267\u2013274","journal-title":"Amyotrop Lat Sclerosis Frontotemporal Degen"},{"issue":"2","key":"4830_CR159","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1179\/174329210X12650506623320","volume":"15","author":"I Spasojevi\u0107","year":"2010","unstructured":"Spasojevi\u0107 I, Stevi\u0107 Z, Nikoli\u0107-Koki\u0107 A, Jones DR, Blagojevi\u0107 D, Spasi\u0107 MB (2010) Different roles of radical scavengers\u2013ascorbate and urate in the cerebrospinal fluid of amyotrophic lateral sclerosis patients. Redox Rep 15(2):81\u201386","journal-title":"Redox Rep"},{"key":"4830_CR160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40478-015-0205-3","volume":"3","author":"C Netzahualcoyotzi","year":"2015","unstructured":"Netzahualcoyotzi C, Tapia R (2015) Degeneration of spinal motor neurons by chronic AMPA-induced excitotoxicity in vivo and protection by energy substrates. Acta Neuropathol Commun 3:1\u20139","journal-title":"Acta Neuropathol Commun"},{"issue":"2","key":"4830_CR161","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S0014-4886(02)00014-6","volume":"179","author":"S Nagano","year":"2003","unstructured":"Nagano S, Fujii Y, Yamamoto T, Taniyama M, Fukada K, Yanagihara T et al (2003) The efficacy of trientine or ascorbate alone compared to that of the combined treatment with these two agents in familial amyotrophic lateral sclerosis model mice. Exp Neurol 179(2):176\u2013180","journal-title":"Exp Neurol"},{"issue":"Suppl 4","key":"4830_CR162","doi-asserted-by":"crossref","first-page":"S683","DOI":"10.33549\/physiolres.934712","volume":"70","author":"H Rauchova","year":"2021","unstructured":"Rauchova H (2021) Coenzyme Q10 effects in neurological diseases. Physiol Res 70(Suppl 4):S683","journal-title":"Physiol Res"},{"issue":"1","key":"4830_CR163","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1038\/s41598-018-19609-2","volume":"8","author":"F Zhang","year":"2018","unstructured":"Zhang F, Zhang Q, Ke Y, Hao J, Lu L, Lu N et al (2018) Serum uric acid levels in patients with amyotrophic lateral sclerosis: a meta-analysis. Sci Rep 8(1):1100","journal-title":"Sci Rep"},{"issue":"3\u20134","key":"4830_CR164","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1080\/21678421.2017.1418005","volume":"19","author":"\u00c9J O\u2019Reilly","year":"2018","unstructured":"O\u2019Reilly \u00c9J, Bjornevik K, Schwarzschild MA, McCullough ML, Kolonel LN, Le Marchand L et al (2018) Pre-diagnostic plasma urate and the risk of amyotrophic lateral sclerosis. Amyotrop Lat Scler Frontotemporal Degen 19(3\u20134):194\u2013200","journal-title":"Amyotrop Lat Scler Frontotemporal Degen"},{"issue":"3","key":"4830_CR165","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1002\/mus.25950","volume":"57","author":"S Paganoni","year":"2018","unstructured":"Paganoni S, Nicholson K, Chan J, Shui A, Schoenfeld D, Sherman A et al (2018) Urate levels predict survival in amyotrophic lateral sclerosis: analysis of the expanded Pooled Resource Open-Access ALS clinical trials database. Muscle Nerve 57(3):430\u2013434","journal-title":"Muscle Nerve"},{"key":"4830_CR166","doi-asserted-by":"crossref","unstructured":"Cryan JF, O'Riordan KJ, Cowan CS, Sandhu KV, Bastiaanssen TF, Boehme M, Codagnone MG, Cussotto S, Fulling C, Golubeva AV, Guzzetta KE (2019) The microbiota-gut-brain axis.\u00a0Physiological reviews","DOI":"10.1152\/physrev.00018.2018"},{"key":"4830_CR167","doi-asserted-by":"crossref","first-page":"1118529","DOI":"10.3389\/fmicb.2023.1118529","volume":"14","author":"K Kasarello","year":"2023","unstructured":"Kasarello K, Cudnoch-Jedrzejewska A, Czarzasta K (2023) Communication of gut microbiota and brain via immune and neuroendocrine signaling. Front Microbiol 14:1118529","journal-title":"Front Microbiol"},{"issue":"2","key":"4830_CR168","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3390\/ani12020145","volume":"12","author":"M Giery\u0144ska","year":"2022","unstructured":"Giery\u0144ska M, Szulc-D\u0105browska L, Struzik J, Mielcarska MB, Gregorczyk-Zboroch KP (2022) Integrity of the intestinal barrier: the involvement of epithelial cells and microbiota\u2014a mutual relationship. Animals 12(2):145","journal-title":"Animals"},{"issue":"6150","key":"4830_CR169","doi-asserted-by":"crossref","first-page":"1241214","DOI":"10.1126\/science.1241214","volume":"341","author":"VK Ridaura","year":"2013","unstructured":"Ridaura VK, Faith JJ, Rey FE, Cheng J, Duncan AE, Kau AL et al (2013) Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science 341(6150):1241214","journal-title":"Science"},{"issue":"10","key":"4830_CR170","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/nrendo.2015.128","volume":"11","author":"EE Canfora","year":"2015","unstructured":"Canfora EE, Jocken JW, Blaak EE (2015) Short-chain fatty acids in control of body weight and insulin sensitivity. Nat Rev Endocrinol 11(10):577\u2013591","journal-title":"Nat Rev Endocrinol"},{"key":"4830_CR171","doi-asserted-by":"crossref","first-page":"1133546","DOI":"10.3389\/fneur.2023.1133546","volume":"14","author":"D Hong","year":"2023","unstructured":"Hong D, Zhang C, Wu W, Lu X, Zhang L (2023) Modulation of the gut\u2013brain axis via the gut microbiota: a new era in treatment of amyotrophic lateral sclerosis. Front Neurol 14:1133546","journal-title":"Front Neurol"},{"issue":"16","key":"4830_CR172","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1093\/hmg\/ddz104","volume":"28","author":"C-O Wong","year":"2019","unstructured":"Wong C-O, Venkatachalam K (2019) Motor neurons from ALS patients with mutations in C9ORF72 and SOD1 exhibit distinct transcriptional landscapes. Hum Mol Genet 28(16):2799\u20132810","journal-title":"Hum Mol Genet"},{"issue":"11","key":"4830_CR173","first-page":"2517","volume":"1852","author":"JK Lee","year":"2015","unstructured":"Lee JK, Shin JH, Lee JE, Choi E-J (2015) Role of autophagy in the pathogenesis of amyotrophic lateral sclerosis. Biochimica et Biophysica Acta (BBA)-Mole Basis Dis 1852(11):2517\u201324","journal-title":"Biochimica et Biophysica Acta (BBA)-Mole Basis Dis"},{"key":"4830_CR174","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.839526","volume":"12","author":"S Martin","year":"2022","unstructured":"Martin S, Battistini C, Sun J (2022) A gut feeling in amyotrophic lateral sclerosis: microbiome of mice and men. Front Cell Infect Microbiol 12:839526","journal-title":"Front Cell Infect Microbiol"},{"key":"4830_CR175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12916-020-01885-3","volume":"19","author":"SL Boddy","year":"2021","unstructured":"Boddy SL, Giovannelli I, Sassani M, Cooper-Knock J, Snyder MP, Segal E et al (2021) The gut microbiome: a key player in the complexity of amyotrophic lateral sclerosis (ALS). BMC Med 19:1\u201314","journal-title":"BMC Med"},{"issue":"2","key":"4830_CR176","first-page":"041947","volume":"13","author":"C Figueroa-Romero","year":"2020","unstructured":"Figueroa-Romero C, Guo K, Murdock BJ, Paez-Colasante X, Bassis CM, Mikhail KA et al (2020) Temporal evolution of the microbiome, immune system and epigenome with disease progression in ALS mice. Disease Models Mech 13(2):041947","journal-title":"Disease Models Mech"},{"key":"4830_CR177","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.neubiorev.2021.06.027","volume":"127","author":"F De Marchi","year":"2021","unstructured":"De Marchi F, Munitic I, Amedei A, Berry JD, Feldman EL, Aronica E et al (2021) Interplay between immunity and amyotrophic lateral sclerosis: clinical impact. Neurosci Biobehav Rev 127:958\u2013978","journal-title":"Neurosci Biobehav Rev"},{"issue":"1","key":"4830_CR178","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/s41392-024-01743-1","volume":"9","author":"JS Loh","year":"2024","unstructured":"Loh JS, Mak WQ, Tan LKS, Ng CX, Chan HH, Yeow SH et al (2024) Microbiota\u2013gut\u2013brain axis and its therapeutic applications in neurodegenerative diseases. Signal Transduct Target Ther 9(1):37","journal-title":"Signal Transduct Target Ther"},{"issue":"5","key":"4830_CR179","doi-asserted-by":"crossref","first-page":"865","DOI":"10.3390\/genes13050865","volume":"13","author":"AC Calvo","year":"2022","unstructured":"Calvo AC, Valledor-Mart\u00edn I, Moreno-Mart\u00ednez L, Toivonen JM, Osta R (2022) Lessons to learn from the gut microbiota: a focus on amyotrophic lateral sclerosis. Genes 13(5):865","journal-title":"Genes"},{"issue":"9","key":"4830_CR180","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1080\/14737175.2019.1623026","volume":"19","author":"PA McCombe","year":"2019","unstructured":"McCombe PA, Henderson RD, Lee A, Lee JD, Woodruff TM, Restuadi R et al (2019) Gut microbiota in ALS: possible role in pathogenesis? Expert Rev Neurother 19(9):785\u2013805","journal-title":"Expert Rev Neurother"},{"issue":"1","key":"4830_CR181","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/s41575-018-0061-2","volume":"16","author":"N Zmora","year":"2019","unstructured":"Zmora N, Suez J, Elinav E (2019) You are what you eat: diet, health and the gut microbiota. Nat Rev Gastroenterol Hepatol 16(1):35\u201356","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"4830_CR182","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.exger.2018.12.005","volume":"115","author":"D Abraham","year":"2019","unstructured":"Abraham D, Feher J, Scuderi GL, Szabo D, Dobolyi A, Cservenak M et al (2019) Exercise and probiotics attenuate the development of Alzheimer\u2019s disease in transgenic mice: role of microbiome. Exp Gerontol 115:122\u2013131","journal-title":"Exp Gerontol"},{"key":"4830_CR183","doi-asserted-by":"crossref","first-page":"256","DOI":"10.3389\/fnagi.2016.00256","volume":"8","author":"E Akbari","year":"2016","unstructured":"Akbari E, Asemi Z, Daneshvar Kakhaki R, Bahmani F, Kouchaki E, Tamtaji OR et al (2016) Effect of probiotic supplementation on cognitive function and metabolic status in Alzheimer\u2019s disease: a randomized, double-blind and controlled trial. Frontiers in aging neuroscience 8:256","journal-title":"Frontiers in aging neuroscience"},{"issue":"2","key":"4830_CR184","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.clinthera.2016.12.014","volume":"39","author":"Y-G Zhang","year":"2017","unstructured":"Zhang Y-G, Wu S, Yi J, Xia Y, Jin D, Zhou J et al (2017) Target intestinal microbiota to alleviate disease progression in amyotrophic lateral sclerosis. Clin Therapeut 39(2):322\u201336","journal-title":"Clin Therapeut"},{"key":"4830_CR185","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.3389\/fmicb.2020.01331","volume":"11","author":"P Marullo","year":"2020","unstructured":"Marullo P, Claisse O, Raymond Eder ML, B\u00f6rlin M, Feghali N, Bernard M et al (2020) SSU1 checkup, a rapid tool for detecting chromosomal rearrangements related to the SSU1 promoter in Saccharomyces cerevisiae: an ecological and technological study on wine yeast. Front Microbiol 11:1331","journal-title":"Front Microbiol"},{"key":"4830_CR186","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12916-020-01607-9","volume":"18","author":"D Di Gioia","year":"2020","unstructured":"Di Gioia D, Bozzi Cionci N, Baffoni L, Amoruso A, Pane M, Mogna L et al (2020) A prospective longitudinal study on the microbiota composition in amyotrophic lateral sclerosis. BMC Med 18:1\u201319","journal-title":"BMC Med"},{"key":"4830_CR187","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12871-017-0465-5","volume":"18","author":"X-D Yang","year":"2018","unstructured":"Yang X-D, Wang L-K, Wu H-Y, Jiao L (2018) Effects of prebiotic galacto-oligosaccharide on postoperative cognitive dysfunction and neuroinflammation through targeting of the gut-brain axis. BMC Anesthesiol 18:1\u201311","journal-title":"BMC Anesthesiol"},{"issue":"3","key":"4830_CR188","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.apsb.2019.07.001","volume":"10","author":"X Yang","year":"2020","unstructured":"Yang X, Yu D, Xue L, Li H, Du J (2020) Probiotics modulate the microbiota\u2013gut\u2013brain axis and improve memory deficits in aged SAMP8 mice. Acta Pharmaceutica Sinica B 10(3):475\u2013487","journal-title":"Acta Pharmaceutica Sinica B"},{"issue":"4","key":"4830_CR189","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.3390\/nu5041417","volume":"5","author":"J Slavin","year":"2013","unstructured":"Slavin J (2013) Fiber and prebiotics: mechanisms and health benefits. Nutrients 5(4):1417\u20131435","journal-title":"Nutrients"},{"issue":"3","key":"4830_CR190","doi-asserted-by":"crossref","first-page":"830S","DOI":"10.1093\/jn\/137.3.830S","volume":"137","author":"M Roberfroid","year":"2007","unstructured":"Roberfroid M (2007) Prebiotics: the concept revisited1. J Nutr 137(3):830S-S837","journal-title":"J Nutr"},{"issue":"12","key":"4830_CR191","volume":"16","author":"Y Xia","year":"2021","unstructured":"Xia Y, Zhang X, Jiang M, Zhang H, Wang Y, Zhang Y et al (2021) In vitro co-metabolism of epigallocatechin-3-gallate (EGCG) by the mucin-degrading bacterium Akkermansia muciniphila. PLoS ONE 16(12):e0260757","journal-title":"PLoS ONE"},{"key":"4830_CR192","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s10096-019-03721-w","volume":"39","author":"Q Le Bastard","year":"2020","unstructured":"Le Bastard Q, Chapelet G, Javaudin F, Lepelletier D, Batard E, Montassier E (2020) The effects of inulin on gut microbial composition: a systematic review of evidence from human studies. Eur J Clin Microbiol Infect Dis 39:403\u2013413","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"9","key":"4830_CR193","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1194\/jlr.R036012","volume":"54","author":"G Den Besten","year":"2013","unstructured":"Den Besten G, Van Eunen K, Groen AK, Venema K, Reijngoud D-J, Bakker BM (2013) The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism. J Lipid Res 54(9):2325\u20132340","journal-title":"J Lipid Res"},{"issue":"12","key":"4830_CR194","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.3390\/antiox10122001","volume":"10","author":"M Ju\u00e1rez-Fern\u00e1ndez","year":"2021","unstructured":"Ju\u00e1rez-Fern\u00e1ndez M, Porras D, Petrov P, Rom\u00e1n-Sag\u00fcillo S, Garc\u00eda-Mediavilla MV, Soluyanova P et al (2021) The synbiotic combination of Akkermansia muciniphila and quercetin ameliorates early obesity and NAFLD through gut microbiota reshaping and bile acid metabolism modulation. Antioxidants 10(12):2001","journal-title":"Antioxidants"},{"issue":"5","key":"4830_CR195","doi-asserted-by":"crossref","first-page":"767","DOI":"10.3390\/biom11050767","volume":"11","author":"PB Gon\u00e7alves","year":"2021","unstructured":"Gon\u00e7alves PB, Sodero ACR, Cordeiro Y (2021) Green tea epigallocatechin-3-gallate (EGCG) targeting protein misfolding in drug discovery for neurodegenerative diseases. Biomolecules 11(5):767","journal-title":"Biomolecules"},{"issue":"1","key":"4830_CR196","volume":"2013","author":"M Kechagia","year":"2013","unstructured":"Kechagia M, Basoulis D, Konstantopoulou S, Dimitriadi D, Gyftopoulou K, Skarmoutsou N et al (2013) Health benefits of probiotics: a review. Int Scholarly Res Notices 2013(1):481651","journal-title":"Int Scholarly Res Notices"},{"issue":"1","key":"4830_CR197","doi-asserted-by":"crossref","first-page":"74","DOI":"10.14336\/AD.2023.0524","volume":"15","author":"S Chen","year":"2024","unstructured":"Chen S, Cai X, Lao L, Wang Y, Su H, Sun H (2024) Brain-gut-microbiota axis in amyotrophic lateral sclerosis: a historical overview and future directions. Aging Dis 15(1):74","journal-title":"Aging Dis"},{"issue":"5","key":"4830_CR198","doi-asserted-by":"crossref","first-page":"590","DOI":"10.3390\/nu16050590","volume":"16","author":"A Noor Eddin","year":"2024","unstructured":"Noor Eddin A, Alfuwais M, Noor Eddin R, Alkattan K, Yaqinuddin A (2024) Gut-modulating agents and amyotrophic lateral sclerosis: current evidence and future perspectives. Nutrients 16(5):590","journal-title":"Nutrients"},{"issue":"14","key":"4830_CR199","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.3390\/nu16142244","volume":"16","author":"P G\u0142owacka","year":"2024","unstructured":"G\u0142owacka P, Oszajca K, Pudlarz A, Szemraj J, Witusik-Perkowska M (2024) Postbiotics as molecules targeting cellular events of aging brain\u2014the role in pathogenesis, prophylaxis and treatment of neurodegenerative diseases. Nutrients 16(14):2244","journal-title":"Nutrients"},{"issue":"2","key":"4830_CR200","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.3390\/ijms24021001","volume":"24","author":"J-AT Matheson","year":"2023","unstructured":"Matheson J-AT, Holsinger RD (2023) The role of fecal microbiota transplantation in the treatment of neurodegenerative diseases: a review. Int J Mole Sci 24(2):1001","journal-title":"Int J Mole Sci"},{"key":"4830_CR201","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.3389\/fneur.2019.01021","volume":"10","author":"J Mandrioli","year":"2019","unstructured":"Mandrioli J, Amedei A, Cammarota G, Niccolai E, Zucchi E, D\u2019Amico R et al (2019) FETR-ALS study protocol: a randomized clinical trial of fecal microbiota transplantation in amyotrophic lateral sclerosis. Front Neurol 10:1021","journal-title":"Front Neurol"},{"issue":"1","key":"4830_CR202","doi-asserted-by":"crossref","first-page":"2353396","DOI":"10.1080\/19490976.2024.2353396","volume":"16","author":"J Yan","year":"2024","unstructured":"Yan J, Chen H, Zhang Y, Peng L, Wang Z, Lan X et al (2024) Fecal microbiota transplantation significantly improved respiratory failure of amyotrophic lateral sclerosis. Gut Microbes 16(1):2353396","journal-title":"Gut Microbes"},{"key":"4830_CR203","doi-asserted-by":"crossref","unstructured":"Niccolai E, Martinelli I, Quaranta G, Nannini G, Zucchi E, De Maio F, Gianferrari G, Bibb\u00f2 S, Cammarota G, Mandrioli J, Masucci L (2024) Fecal microbiota transplantation in amyotrophic lateral sclerosis: clinical protocol and evaluation of microbiota immunity axis. In: Neuroprotection: Method and Protocols,\u00a0Springer US, New York, NY, pp 373\u2013396","DOI":"10.1007\/978-1-0716-3662-6_27"},{"issue":"6","key":"4830_CR204","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.cell.2020.04.027","volume":"181","author":"QY Ang","year":"2020","unstructured":"Ang QY, Alexander M, Newman JC, Tian Y, Cai J, Upadhyay V et al (2020) Ketogenic diets alter the gut microbiome resulting in decreased intestinal Th17 cells. Cell 181(6):1263\u201375.e16","journal-title":"Cell"},{"key":"4830_CR205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13229-016-0099-3","volume":"7","author":"C Newell","year":"2016","unstructured":"Newell C, Bomhof MR, Reimer RA, Hittel DS, Rho JM, Shearer J (2016) Ketogenic diet modifies the gut microbiota in a murine model of autism spectrum disorder. Molecular autism 7:1\u20136","journal-title":"Molecular autism"},{"key":"4830_CR206","doi-asserted-by":"crossref","first-page":"1015837","DOI":"10.3389\/fnagi.2022.1015837","volume":"14","author":"S Kaviyarasan","year":"2022","unstructured":"Kaviyarasan S, Chung Sia EL, Retinasamy T, Arulsamy A, Shaikh MF (2022) Regulation of gut microbiome by ketogenic diet in neurodegenerative diseases: a molecular crosstalk. Front Aging Neurosci 14:1015837","journal-title":"Front Aging Neurosci"},{"issue":"7","key":"4830_CR207","doi-asserted-by":"crossref","first-page":"534","DOI":"10.3390\/genes10070534","volume":"10","author":"A Paoli","year":"2019","unstructured":"Paoli A, Mancin L, Bianco A, Thomas E, Mota JF, Piccini F (2019) Ketogenic diet and microbiota: friends or enemies? Genes 10(7):534","journal-title":"Genes"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-04830-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-025-04830-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-04830-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T15:10:34Z","timestamp":1751382634000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-025-04830-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,17]]},"references-count":207,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["4830"],"URL":"https:\/\/doi.org\/10.1007\/s12035-025-04830-8","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,17]]},"assertion":[{"value":"4 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"All authors have read the final version of the manuscript and declared their consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}